SCHEMBL669382

SCHEMBL669382

CC[C@](c1cccc(O)c1)(C(C)C)N(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 6/20 0.43
SLC22A1 O15245 1/20 0.43
ALDH1A1 P00352 2/20 0.39
CYP3A4 P08684 1/20 0.39
KIF11 P52732 1/20 0.38
OPRK1 P41145 6/20 0.38
OPRD1 P41143 5/20 0.38
TSHR P16473 2/20 0.38
DRD3 P35462 4/20 0.37
DRD2 P14416 3/20 0.37
DRD1 P21728 2/20 0.37
DRD4 P21917 1/20 0.37
DRD5 P21918 1/20 0.37
ADRB1 P08588 2/20 0.37
ADRA1A P35348 2/20 0.37
MIF P14174 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2B P41595 1/20 0.37
HIF1A Q16665 2/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2588173 1.00 OPRM1 (0.43) OPRM1SLC22A1ALDH1A1CYP3A4KIF11
Hydrochloric Acid SCHEMBL15109984 0.98 OPRM1 (0.42) OPRM1SLC22A1ALDH1A1CYP3A4KIF11
Hydrochloric Acid SCHEMBL15109953 0.98 OPRM1 (0.42) OPRM1SLC22A1ALDH1A1CYP3A4KIF11
SCHEMBL2009362 0.73 L3MBTL1 (0.50) ALDH1A1CYP3A4LMNARAB9A
SCHEMBL393199 0.73 ESR1 (0.58) OPRM1ALDH1A1CYP3A4KIF11TSHR
SCHEMBL10868376 0.71 ALDH1A1 (0.48) ALDH1A1CYP3A4KIF11TSHRLMNA
SCHEMBL3899366 0.71 ALDH1A1 (0.50) OPRM1SLC22A1ALDH1A1CYP3A4KIF11
SCHEMBL2554077 0.71 ALDH1A1 (0.50) OPRM1SLC22A1ALDH1A1CYP3A4KIF11
SCHEMBL174568 0.71 ALDH1A1 (0.50) OPRM1SLC22A1ALDH1A1CYP3A4KIF11
SCHEMBL4495715 0.71 ALDH1A1 (0.50) OPRM1SLC22A1ALDH1A1CYP3A4KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013105109-A1 PROCESS FOR THE PREPARATION OF TAPENTADOL INDOCO REMEDIES LIMITED (IN) 2013-07-18 WO claimed
EP-2606030-A1 PROCESS FOR THE PREPARATION OF TAPENTADOL Indoco Remedies Limited (IN) 2013-06-26 EP claimed
WO-2012023147-A1 PROCESS FOR THE PREPARATION OF TAPENTADOL INDOCO REMEDIES LIMITED (IN) 2012-02-23 WO claimed
EP-3819287-B1 AMORPHOUS TAPENTADOL PHOSPHATE RATIOPHARM GMBH (DE) 2023-09-20 EP disclosed
EP-3653599-B1 CRYSTALLINE TAPENTADOL PHOSPHATE RATIOPHARM GMBH (DE) 2022-12-14 EP disclosed
EP-3947342-A1 PROCESS FOR THE PREPARATION OF TAPENTADOL AND ANALOGS THEREOF Council of Scientific and Industrial Research (IN) 2022-02-09 EP disclosed
EP-3819287-A1 AMORPHOUS TAPENTADOL PHOSPHATE ratiopharm GmbH (DE) 2021-05-12 EP disclosed
WO-2020194326-A1 PROCESS FOR THE PREPARATION OF TAPENTADOL AND ANALOGS THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2020-10-01 WO disclosed
EP-3653599-A1 CRYSTALLINE TAPENTADOL PHOSPHATE ratiopharm GmbH (DE) 2020-05-20 EP disclosed
EP-3445742-B1 CRYSTALLINE TAPENTADOL PHOSPHATE RATIOPHARM GMBH (DE) 2019-11-13 EP disclosed
EP-3063125-A1 NOVEL INTERMEDIATE OF TAPENTADOL Sun Pharma Advanced Research Company (IN) 2016-09-07 EP disclosed
WO-2015075744-A1 NOVEL INTERMEDIATE OF TAPENTADOL SUN PHARMA ADVANCED RESEARCH COMPANY (IN) 2015-05-28 WO disclosed
WO-2015075678-A1 A NOVEL PROCESS FOR THE PREPARATION OF 1-PHENYL-3-AMINOPROPANE DERIVATIVES UNIMARK REMEDIES LTD. (IN) 2015-05-28 WO disclosed
WO-2014108514-A1 TAPENTADOL MALEATE AND CRYSTALLINE FORMS THEREOF FARMA GRS, D. O. O. (SI) 2014-07-17 WO disclosed
WO-2013105109-A1 PROCESS FOR THE PREPARATION OF TAPENTADOL INDOCO REMEDIES LIMITED (IN) 2013-07-18 WO disclosed
WO-2013105753-A1 SUBSTITUTED PIPERIDINE DERIVATIVES AND METHODS FOR PREPARING THE SAME HYUNDAI PHARM CO., LTD. (KR) 2013-07-18 WO disclosed
EP-2606030-A1 PROCESS FOR THE PREPARATION OF TAPENTADOL Indoco Remedies Limited (IN) 2013-06-26 EP disclosed
WO-2012025213-A2 NOVEL THERAPEUTIC COMPOUNDS Grünenthal GmbH (DE) 2012-03-01 WO disclosed
WO-2012023147-A1 PROCESS FOR THE PREPARATION OF TAPENTADOL INDOCO REMEDIES LIMITED (IN) 2012-02-23 WO disclosed
WO-2011154148-A1 NOVEL THERAPEUTIC COMPOUNDS Grünenthal GmbH (DE) 2011-12-15 WO disclosed